Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Phase 2
290
about 6.4 years
18+
8 sites in CA, CT, NY +3
What this study is about
Researchers are testing whether N-acetylcysteine (NAC), a treatment, can help people with SLE. The trial will involve titrating to tolerance during an initial 3 month open label period and then subjects will be randomized to one of two arms. After A 3-month open-label dose-titration phase, SLE subjects will be randomized into 2 groups of 105 subjects either to continue the tolerated dosage of NAC or switched to equal number of placebo capsules.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take N-acetylcysteine
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
acetylcysteine
oral (Oral Capsule)
Immune